Biogenesis-Bago invests in FMD vaccine biosecurity technology
Biogenesis-Bago is to modernize and expand the biosecurity and production technology used in its foot and mouth disease vaccines facility. The Argentine company, based in Buenos Aires, says that the upgrades will improve existing measures at the plant. It plans to install new systems, including automated ones, instruments, effluent and air treatments, software and other new equipment. Biogenesis-Bago renovated its purification and quarantine units, cultivation methods and packaging between 2002 and 2004.